IRB Advisor – December 1, 2007
December 1, 2007
View Issues
-
Building an IRB to ensure rights of subjects in a developing nation
Medical research in developing countries often is conducted by Western institutions, using their own IRBs to ensure the rights of participants who could be half a world away. -
Rare diseases research brings special challenges
Those advocating research into rare diseases often have an uphill battle, searching for funding and trying to garner public support for treating conditions that don't have the same widespread recognition as HIV or breast cancer. -
IRB staff and managers need these survival skills
One of the truest sayings an IRB professional might hear is that you can't have burnout unless it's a really bright light to begin with, an expert says. -
Starting or expanding an IRB office? It helps to know size, scope, culture
When planning to expand an IRB office or start a new one to support one or more IRBs, the key principle to keep in mind is that one size does not fit all when it comes to IRBs, an expert says. -
Illegal drug-using subjects pose unique ethical challenges
IRBs reviewing protocols involving HIV drug-using populations sometimes find that it's impossible to anticipate all of the ethical issues that will arise during the trials. -
Organ transplant research: Do we need a central IRB?
A patient needing a transplant for a vital human organ often waits months or even years before one becomes available. -
Organ transplant research: Do we need a central IRB?
A patient needing a transplant for a vital human organ often waits months or even years before one becomes available.